DrugInfoSys

Anti-rabies vaccine

Drug #2178

Anti-rabies vaccine is the immunization which prevents infection with the virus that causes rabies. Anti-rabies vaccine is given for Category II (minor scratches without bleeding from contact, or licks on broken skin) and Category III (one or more bites, scratches, licks on broken skin, or other contact that breaks the skin; or exposure to bats) exposures. Antirabies vaccines are of 2 types-Neural and Non-neural vaccines. Though neural tissue vaccines are not directed by WHO to use by its member nations, still these vaccines are used in many developing nations because of their low cost. Non-neural vaccines were developed for reducing the neuroparalytic complications associated with the nervous tissue vaccines.

Primary Characteristics

It is of Semi Synthetic origin.

Non-proprietary name: Anti-rabies vaccine.

Molecular structure of Anti-rabies vaccine

Pharmacokinetics

None recorded.

Advertisement

Indications

Contraindications

None recorded.

Dosage

None recorded.

Drug Interactions

None recorded.

Side Effects

Anti-rabies vaccine is known to cause more or less tolerable side effects which are usually transient. These include Dizziness, Gastrointestinal disturbances, Headache, Hypersensitivity reactions, Itching, Local pain, Malaise.

Warnings / Precautions

Health staff must be well trained in techniques and vaccines must be stored appropriately for effectiveness. WHO recommends that toddlers and children in highly endemic areas may also be considered for rabies pre exposure vaccination.

Available Brands

None recorded.

Drug Classification

  1. 1.19.3.2Vaccines for specific groups of individuals